David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Genuine Parts
GPC
$19.2B
| $3.91M | ﹤0.01% |
36,794
-81,707
| -69% | -$8.4M |
|
1877
Flowserve
FLS
$10.5B
| $3.91M | ﹤0.01% |
78,531
+38,513
| +96% | +$1.84M |
|
1878
Campbell Soup
CPB
$6.93B
| $3.9M | ﹤0.01% |
78,897
+9,138
| +13% | +$433K |
|
1879
CALL
Verisk Analytics
VRSK
$24.5B
| $3.9M | ﹤0.01% |
26,100
| – | – |
|
1880
AtriCure
ATRC
$2.45B
| $3.89M | ﹤0.01% |
119,769
+18,294
| +18% | +$521K |
|
1881
PUT
Novartis
NVS
$299B
| $3.89M | ﹤0.01% |
+41,100
| New | +$3.69M |
|
|
MRTX
1882
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.89M | ﹤0.01% |
30,200
+20,000
| +196% | +$1.93M |
|
|
KSU
1883
CALL
DELISTED
Kansas City Southern
KSU
| $3.89M | ﹤0.01% |
+25,400
| New | +$3.73M |
|
1884
PUT
United Therapeutics
UTHR
$22.2B
| $3.88M | ﹤0.01% |
44,100
-9,200
| -17% | -$810K |
|
1885
W.R. Berkley
WRB
$25.5B
| $3.88M | ﹤0.01% |
+126,338
| New | +$3.9M |
|
|
VNET
1886
VNET Group
VNET
$1.88B
| $3.88M | ﹤0.01% |
534,492
+15,338
| +3% | +$116K |
|
1887
CALL
Rockwell Automation
ROK
$47.9B
| $3.87M | ﹤0.01% |
19,100
+14,100
| +282% | +$2.61M |
|
1888
CALL
NIO
NIO
$10.9B
| $3.86M | ﹤0.01% |
961,100
+875,900
| +1,028% | +$1.76M |
|
1889
PUT
Alexandria Real Estate Equities
ARE
$9.12B
| $3.86M | ﹤0.01% |
23,900
+600
| +3% | +$94.6K |
|
1890
Genesco
GCO
$384M
| $3.86M | ﹤0.01% |
80,595
-65,480
| -45% | -$2.72M |
|
1891
First Citizens BancShares
FCNCA
$24.6B
| $3.86M | ﹤0.01% |
7,255
-3,884
| -35% | -$1.97M |
|
1892
CALL
Equity Lifestyle Properties
ELS
$12.5B
| $3.86M | ﹤0.01% |
54,800
+12,800
| +30% | +$890K |
|
1893
CALL
Williams-Sonoma
WSM
$28B
| $3.85M | ﹤0.01% |
+104,800
| New | +$3.64M |
|
1894
CALL
Zscaler
ZS
$27.5B
| $3.85M | ﹤0.01% |
82,700
-33,500
| -29% | -$1.55M |
|
1895
Ribbon Communications
RBBN
$363M
| $3.84M | ﹤0.01% |
1,239,041
+205,740
| +20% | +$819K |
|
1896
Vishay Intertechnology
VSH
$4.7B
| $3.84M | ﹤0.01% |
180,300
-185,192
| -51% | -$3.59M |
|
|
SIX
1897
PUT
DELISTED
Six Flags Entertainment Corp.
SIX
| $3.83M | ﹤0.01% |
+84,900
| New | +$3.91M |
|
1898
Independent Bank Corp
IBCP
$815M
| $3.83M | ﹤0.01% |
168,970
+6,110
| +4% | +$135K |
|
|
UFS
1899
PUT
DELISTED
DOMTAR CORPORATION (New)
UFS
| $3.82M | ﹤0.01% |
100,000
| – | – |
|
1900
PUT
Agios Pharmaceuticals
AGIO
$2.03B
| $3.82M | ﹤0.01% |
80,000
+10,000
| +14% | +$378K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.91B in Q4 2019, closing 412 positions and reducing 1,498 holdings. Its most notable exit was Celgene Corp, an estimated $460M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Tesla worth $501M.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.